Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01848353 · ClinicalTrials.gov registry record · NA

Financial Incentives to Exercise for Adolescents

A NA study of Obesity and Insulin Resistance, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
142
Enrollment target
2
Study locations

NCT01848353: Completed NA study of Obesity and Insulin Resistance, sponsored by University of Oklahoma.

NCT01848353 is a NA study of Obesity and Insulin Resistance that has completed, run by University of Oklahoma. The registered enrollment target is 142 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01848353, a NA study of Obesity and Insulin Resistance, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
142 participants
Enrollment target
2
Study locations

Study Summary

Among youth populations, American Indians have the highest prevalence of diabetes in the United States. This study will use exercise as the principal lifestyle modification approach to reduce the risk of diabetes in this population. The Choctaw Nation of Oklahoma has several excellent, but underutilized wellness facilities in their Health Services Area in rural Southeast Oklahoma, a low socioeconomic region. It has been established that exercise lowers diabetes risk, and many overweight/obese, insulin resistant American Indian youth who live in this region would benefit from an increase in regular exercise. The challenge is to modify behavior so that routine exercise is established and maintained. The proposed study will test whether monetary incentives can elicit greater frequency and duration of exercise in American Indian youth when transportation and access barriers are reduced.

Primary Outcome

Frequency and duration of moderate-to-vigorous physical activity will be measured using heart rate monitors. The monitors will be worn each exercise session. Participants are asked to complete 3 exercise sessions per week throughout the 48-week period of enrollment. The primary comparison between the experimental and active comparator groups will be the volume of exercise (total time) accumulated. Comparisons will be made for accumulated exercise volume at 16, 32, and 48 weeks and the change fro

Interventions

  • BEHAVIORAL Exercise training

Study Locations (2)

Oklahoma

  • Choctaw Nation of Oklahoma Healthcare - Hugo
  • Choctaw Nation Diabetes Wellness Center - Talihina

Trial Details

FieldValue
Enrollment Target 142 participants
Start Date 2013-05
Est. Completion 2017-05
Phase NA
University of Oklahoma

358 total trials

What the finished NCT01848353 record still lists

NCT01848353 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (83% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Exercise training is the first listed.

NCT01848353 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT01848353 about?

NCT01848353 is a clinical study titled "Financial Incentives to Exercise for Adolescents". Among youth populations, American Indians have the highest prevalence of diabetes in the United States. This study will use exercise as the principal lifestyle modification approach to reduce the risk of diabetes in this population. The Choctaw Nation of Oklahoma has several excellent, but underutil...

What is the current status of trial NCT01848353?

This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2013-05. Estimated completion is 2017-05.

What conditions does trial NCT01848353 study?

This clinical trial studies the following conditions: Obesity, Insulin Resistance, Sedentary Lifestyle.

What interventions are being tested in trial NCT01848353?

The interventions under investigation include: Exercise training (BEHAVIORAL).

Who is sponsoring clinical trial NCT01848353?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01848353 being conducted?

This trial has 2 study locations across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01848353's enrollment target sits among peer trials

142 398th of 1053 higher than 656 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03933631 · 142 participants · Phase 3

    Pilocarpine Use After Kahook Goniotomy

  • NCT04938349 · 142 participants · NA

    Dual Task Perturbation Training for OAwMCI

  • NCT06117254 · 142 participants · NA

    Hearing Aids for Veterans With Functional Hearing Difficulties

  • NCT06463665 · 142 participants · Phase 2

    Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01848353, the US trial registry maintained by the National Library of Medicine. NCT01848353 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.